about
Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Redesigning the AIDS response for long-term impact.The Blame Game: Stigma and HIV/AIDS in an African MetropolisNanostructured optical photonic crystal biosensor for HIV viral load measurement.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Global health and foreign policy.A review of management of infertility in Nigeria: framing the ethics of a national health policy.Partnering for Care in HIV Prevention TrialsLife expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice.The emergence and evolution of the research fronts in HIV/AIDS research.AMPATH: living proof that no one has to die from HIV.Food insufficiency, substance use, and sexual risks for HIV/AIDS in informal drinking establishments, Cape Town, South Africa.Immunological effect of aqueous extract of Vernonia amygdalina and a known immune booster called immunace(®) and their admixtures on HIV/AIDS clients: a comparative study.The human/animal interface: emergence and resurgence of zoonotic infectious diseases.Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.A patent review of the therapeutic potential of isoflavones (2012-2016).'Triangulating' AMPATH: demonstration of a multi-perspective strategic programme evaluation method.Target-selective photodegradation of HIV-1 protease and inhibition of HIV-1 replication in living cells by designed fullerene-sugar hybrids.Traditional Chinese medicine could increase the survival of people living with HIV in rural central China: a retrospective cohort study, 2004-2012.Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients.Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages.Randomized clinical trial of brief risk reduction counseling for sexually transmitted infection clinic patients in Cape Town, South Africa
P2860
Q30364647-CF63B114-B7A1-408F-8020-B9CEB39B6205Q30409479-CEA59124-40B5-4506-9038-7E2908CF3537Q30423010-921966B4-5314-4064-9089-7BE571B80721Q30442145-9B204A07-27BB-461D-99CA-39DE5E1C5773Q33819656-BF496FD8-3C44-4A06-89A6-D0A226744CB2Q33969512-D516FDC1-EFB9-4449-836A-CB605D44FB26Q35186170-AD759CDF-FC95-4374-B987-DDDDE27434D8Q35629374-D2ED8B8E-8FDA-40EF-943D-90236767CE7DQ35693918-2DFF38D1-2EDA-4ED1-A8C6-774A8726F6D6Q35729350-2A969CBB-153D-4C28-AAA6-CE1D717BF5E4Q36380956-07E0EEBC-8105-4F03-9336-E6207377C44CQ36416972-329396B5-B843-4529-88CB-C075A6B2C84BQ36491920-F1F6B0DF-6E5E-4623-B608-9AFE47EA0A78Q36719642-97F3C4D4-CBBA-4F84-91E8-8723997F1E54Q37011494-8280F16C-1E22-466D-8FE3-F4B08431DEF5Q37780687-EB9B43F5-A734-4B44-9034-98623A174633Q38674207-D1620130-EC44-4C3E-BB6F-6E1A2B691011Q39094703-2D909E6F-DC7B-4FD6-A504-859E600B13A2Q39387906-4E66CD3F-D1F6-454D-9CBB-1A3B38DBC270Q41613066-3DE45644-C3C7-40B1-AF0D-56B3625C8BDDQ43276350-E5922E52-9D63-4F84-8BEE-BE57DC25C659Q55558410-7A467EC6-54FC-4642-B847-AE0479C57536Q56914615-D813B9EC-8B90-4F8C-99A2-A957BE1A5E3D
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The HIV-AIDS pandemic at 25--the global response.
@ast
The HIV-AIDS pandemic at 25--the global response.
@en
type
label
The HIV-AIDS pandemic at 25--the global response.
@ast
The HIV-AIDS pandemic at 25--the global response.
@en
prefLabel
The HIV-AIDS pandemic at 25--the global response.
@ast
The HIV-AIDS pandemic at 25--the global response.
@en
P356
P1476
The HIV-AIDS pandemic at 25--the global response.
@en
P2093
Michael H Merson
P304
P356
10.1056/NEJMP068074
P407
P577
2006-06-01T00:00:00Z